Low dose pegylated recombinant human granulocyte colony-stimulating factor in the prophylactic treatment of grade Ⅲ/Ⅳ myelosuppression after chemotherapy
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 10
Abstract
"Objective To investigate the impact of low-dose pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) on grade Ⅲ/Ⅳ myelosuppression following chemotherapy. Methods A total of 80 patients with malignant tumors admitted to the First Affiliated Hospital of Anhui University of Science and Technology from April 2022 to September 2023 were selected as research subjects. The patients were randomly divided into the control group (n=40) and the observation group (n=40). The observation group and the control group received subcutaneous injections of 3.0 mg and 6.0 mg PEG-rhG-CSF, respectively, within 24 to 48 hours after chemotherapy. The incidence and duration of grade Ⅲ/Ⅳ neutropenia, febrile neutropenia (FN), adverse reactions, as well as changes in quality of life ［European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)］ scores before and after treatment were observed in both groups after medication. Results After medication, there was no significant difference in the incidence of grade Ⅲ/Ⅳ neutropenia or FN between the two groups (P＞0.05). The observation group exhibited higher levels for neutrophils compared to control group ［(1.77±0.70)×109/L vs (1.50±0.41)×109/L, t=2.071, P=0.042］. Grade Ⅲ/Ⅳ neutropenia occurred in 1 case in the control group, which lasted for 1 day, while 3 cases occurred in the observation group, which lasted for 2-4 days. Compared with the control group, the occurrence rate of adverse reactions was lower in the observation group (72.50% vs 90.00%, χ<sup>2</sup>=4.021, P=0.045), and EORTC QLQ-C30 were higher for patients in the observation group (P＜0.05). Conclusion Low-dose PEG-rhG-CSF demonstrates similar efficacy rates as standard doses for prophylactic managing gradeⅢ/Ⅳ myelosuppression following chemotherapy, but it exhibits a lower incidence rate of adverse reactions and improves quality-of-life of patients."
Authors and Affiliations
WANG Jin, TIE Xiaowei, FU Baobao, JIA Qianqian, WANG Fang, LI Wei
Keywords
Related Articles
- EP ID EP749061
- DOI -
- Views 43
- Downloads 0
Research progress on mitochondrial mechanisms of sensitivity to inhalational anesthetics
Experimental animals and people have different sensitivity to inhalational anesthetics, which is related to the depth of anesthesia during general anesthesia and the perioperative safety of patients. Studying the mechani...
Application of predictive nursing in chemotherapy nursing of lung cancer based on risk management theory
Objective To explore the application value of predictive nursing based on risk management theory in nursing of lung cancer patients undergoing chemotherapy. Methods Ninety-eight lung cancer patients receiving chemotherap...
Relationship between polyamines and polyamine metabolism with malignant tumors
Polyamines such as spermine, spermidine, and putrescine play pivotal roles in the proliferation, differentiation, and development of eukaryotes. Multiple regulatory mechanisms strictly control intracellular polyamine con...
Correlation between serum manganese and non-alcoholic fatty liver disease
Objective To investigate the relationship between serum manganese (Mn) levels and non-alcoholic fatty liver disease (NAFLD) in individuals of different genders. Methods Participants aged 18 years or older from the Nation...
Correlation between visceral fat area and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus
"<b>Objective</b> To investigate the effect of visceral fat area (VFA) on carotid atherosclerotic plaque in patients with type 2 diabetes mellitus(T2DM). <b>Methods</b> From August 2018 to August 2023, 683 T2DM patient...